Axon Enterprise, Inc. (NASDAQ:AXON) is Motley Fool Asset Management LLC’s 6th Largest Position

Motley Fool Asset Management LLC trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 145,302 shares of the biotechnology company’s stock after selling 1,462 shares during the quarter. Axon Enterprise comprises 2.8% of Motley Fool Asset Management LLC’s portfolio, making the stock its 6th largest holding. Motley Fool Asset Management LLC’s holdings in Axon Enterprise were worth $37,536,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in the stock. Sands Capital Management LLC raised its position in Axon Enterprise by 31.1% during the third quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock valued at $519,823,000 after acquiring an additional 619,179 shares in the last quarter. Westfield Capital Management Co. LP raised its position in Axon Enterprise by 184.3% during the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock valued at $138,535,000 after acquiring an additional 451,350 shares in the last quarter. Polar Capital Holdings Plc raised its position in Axon Enterprise by 292.0% during the third quarter. Polar Capital Holdings Plc now owns 265,464 shares of the biotechnology company’s stock valued at $52,825,000 after acquiring an additional 197,746 shares in the last quarter. Bank of New York Mellon Corp raised its position in Axon Enterprise by 28.3% during the third quarter. Bank of New York Mellon Corp now owns 726,400 shares of the biotechnology company’s stock valued at $144,546,000 after acquiring an additional 160,359 shares in the last quarter. Finally, International Assets Investment Management LLC bought a new position in Axon Enterprise during the fourth quarter valued at approximately $39,907,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

AXON has been the topic of several analyst reports. JMP Securities increased their price target on Axon Enterprise from $250.00 to $285.00 and gave the company a “market outperform” rating in a report on Tuesday, February 6th. StockNews.com downgraded Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. The Goldman Sachs Group increased their price target on Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. Argus initiated coverage on Axon Enterprise in a report on Wednesday, March 13th. They set a “buy” rating and a $380.00 price target on the stock. Finally, Robert W. Baird increased their price target on Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, February 22nd. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $312.64.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock traded up $3.83 during midday trading on Thursday, hitting $306.24. The company had a trading volume of 305,890 shares, compared to its average volume of 469,582. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $329.87. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The business’s 50 day simple moving average is $302.78 and its two-hundred day simple moving average is $260.58. The stock has a market cap of $23.11 billion, a PE ratio of 133.15 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.29. The firm had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. As a group, equities analysts predict that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.